Manitou Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
189,563
+5,368
+3% +$450K 3.19% 10
2026
Q1
$14.8M Sell
184,195
-546
-0.3% -$45K 2.92% 11
2025
Q4
$15.7M Buy
184,741
+1,495
+0.8% +$123K 2.76% 13
2025
Q3
$14.3M Sell
183,246
-2,406
-1% -$188K 2.49% 13
2025
Q2
$14.5M Sell
185,652
-4,004
-2% -$299K 2.76% 13
2025
Q1
$13.7M Buy
189,656
+10,205
+6% +$730K 2.67% 14
2024
Q4
$13.3M Buy
179,451
+32,781
+22% +$2.29M 2.62% 15
2024
Q3
$9.68M Buy
146,670
+146,423
+59,281% +$10.6M 1.84% 17
2024
Q2
$22.8K Hold
247
0.01% 41
2024
Q1
$23.6K Hold
247
﹤0.01% 40
2023
Q4
$18.8K Hold
247
﹤0.01% 42
2023
Q3
$17.1K Hold
247
﹤0.01% 41
2023
Q2
$23.3K Hold
247
0.01% 37
2023
Q1
$20.4K Buy
+247
New +$19.4K 0.01% 48
2019
Q1
Sell
-237,954
Closed -$10M 43
2018
Q4
$10M Buy
237,954
+234,390
+6,577% +$11.9M 2.18% 22
2018
Q3
$207K Buy
+3,564
New +$174K 0.05% 38
2018
Q2
Sell
-229,944
Closed -$10.7M 31
2018
Q1
$10.7M Buy
229,944
+690
+0.3% +$30K 3.32% 14
2017
Q4
$8.61M Buy
229,254
+207,714
+964% +$7.62M 2.46% 18
2017
Q3
$785K Hold
21,540
0.24% 23
2017
Q2
$849K Sell
21,540
-21,060
-49% -$769K 0.25% 25
2017
Q1
$1.34M Hold
42,600
0.37% 30
2016
Q4
$1.33M Buy
+42,600
New +$1.38M 0.39% 30

Other funds holding EW

Manitou Investment Management's EW Position: Q2 2026 in Review

Manitou Investment Management increased its Edwards Lifesciences (EW) stake by 2.9% in Q2 2026, buying an estimated $450K and bringing the position to 189,563 shares worth $17.1M. The position accounts for 3.19% of the portfolio, ranked #10.

Manitou Investment Management first reported a position in EW in Q4 2016 and has held it in 22 quarters since. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Manitou Investment Management held 189,563 shares of Edwards Lifesciences worth $17.1M as of Q2 2026.
  • Manitou Investment Management bought 5,368 Edwards Lifesciences shares in Q2 2026, an estimated $450K.
  • Edwards Lifesciences made up 3.19% of Manitou Investment Management's portfolio in Q2 2026, its #10 holding.
  • Manitou Investment Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 22 quarters since.
  • 458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Manitou Investment Management's 13F filing for Q2 2026, filed 7 Jul 2026.